Abstract:Objective To investigate the effect of exendin-4, a glucagon-like peptide-1 ( GLP-1) receptor agonist , on reducing lipid deposition and improving insulin resistance in skeletal muscle and the underlying mechanisms in high-fat diet ( HFD)-induced obese mice.Methods Twelve male C57BL/6J mice were challenged with HFD for 12 weeks to induce obesity and then randomly divided into two groups:exendin-4 group (intraperitoneal injection of 24 nmol· kg-1 · d-1 exendin-4 for 4 weeks) and HFD group (intraperitoneal injection of normal saline for 4 weeks), with 6 mice in each group.Additional 6 mice were also selected as control group.Body weight , fasting blood glucose were recorded .Serum triglyceride ( TG) , total cholesterol ( TC ) , insulin and skeletal muscle triglyceride levels were measured by enzyme-linked immunosobent assay ( ELISA).Oil red O staining was used for morphologic changes of frozen sections from skeletal muscle.The protein levels of lipid metabolic pathway mediated by AMP-activated protein kinase ( AMPK) and insulin signailing pathway were determined by Western blot.Results Compared with mice in HFD group, exendin-4 significantly decreased body weight [(37.68 ±1.80) vs (46.03 ±5.00) g, P<0.025], fasting blood glucose[(5.40 ±0.33) vs (7.65 ±1.92) mmol/L, P<0.025], serum TG[(37.78 ± 7.14) vs (80.76 ±34.22) mg/dl, P<0.025], TC[(180.13 ±18.75) vs (217.57 ±22.52) mg/dl, P<0.025], insulin [(0.58 ±0.01) vs (1.67 ±1.23) ng/ml, P<0.025] and skeletal muscle TG levels [(9.84 ±1.08) vs (19.35 ±7.44) mg/g, P<0.025] of obese mice.Oil red O staining revealed that exendin-4 alleviated the accumulation of larger lipid droplets in skeletal muscle.The protein expressions of lipolysis and lipid oxidation mediated by AMPK and insulin signailing pathway were up -regulated, and the protein expressions of lipogenesis mediated by AMPK were down-regulated after intervention of exendin-4. Conclusion Exendin-4 reduces lipid deposition and insulin resistance in skeletal muscle of HFD-induced obese mice via activating AMPK and up-regulating insulin signailing pathway.

Effects of Exendin-4 on Glucose and Lipid Metabolism in Diabetic Rats

Effects of Exendin-4 on Glucose Metabolism and Pdx-1 Mrna Expression in OLETF Rat

Effects of Glucagon-Like Peptide-1 Analogue (Exendin-4) on the Function of Β-Cell and Insulin Resistance in OLETF Diabetic Rats

Effects of Exenatide on Lipid Metabolism of Adipose Tissue in Diabetic Rats

Long-term Effect of Exendin-4 on Weight Reduction of Normal Rats

Exendin-4 Improves Diabetic Kidney Disease in C57BL/6 Mice Independent of Brown Adipose Tissue Activation

Effect of Exendin-4 on Lipid Deposition in Skeletal Muscle of Diet-Induced Obese Mice and Its Underlying Mechanism

Exendin-4 Improves Glucose Metabolism in Insulin-Resistant Cells by Upregulating the Phosphorylative AMPK

Sustained Release of Exendin-4 from Tannic Acid/fe (III) Nanoparticles Prolongs Blood Glycemic Control in a Mouse Model of Type II Diabetes.

Effects of Exenatide Therapy on Insulin Resistance in the Skeletal Muscles of High-Fat Diet and Low-Dose Streptozotocin-Induced Diabetic Rats.

Exendin-4, a GLP-1 receptor agonist, stimulates entero-insular axis in the rat, through a mechanism involving adrenal medulla

The glucose-lowering potential of exendin-4 orally delivered via a pH-sensitive nanoparticle vehicle and effects on subsequent insulin secretion in vivo

Pharmacokinetic/pharmacodynamic Studies on Exenatide in Diabetic Rats

Mechanism of Effects of Emodin on Gastric Dynamics in Type 2 Diabetic Rats

Exendin-4 protects retinal cells from early diabetes in Goto-Kakizaki rats by increasing the Bcl-2/Bax and Bcl-xL/Bax ratios and reducing reactive gliosis.

Immunoregulation Effects of Exendin-4 on Peripheral Blood Mononuclear Cells in Patients with Type 1 Diabetes Mellitus

Amelioration of Neurodegenerative Changes in Cellular and Rat Models of Diabetes-Related Alzheimer's Disease by Exendin-4.

GLP-1 Receptor Agonist Improves Mitochondrial Energy Status and Attenuates Nephrotoxicity In Vivo and In Vitro

The GLP-1 Analogue Exenatide Improves Hepatic and Muscle Insulin Sensitivity in Diabetic Rats: Tracer Studies in the Basal State and During Hyperinsulinemic-Euglycemic Clamp.

Exendin-4 improves long-term potentiation and neuronal dendritic growth in vivo and in vitro obesity condition

Exendin-4 Ameliorates Lipotoxicity-induced Glomerular Endothelial Cell Injury by Improving ABC Transporter A1-mediated Cholesterol Efflux in Diabetic Apoe Knockout Mice